Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Feb 28 04:00PM ET
Dollar change
Percentage change
Index- P/E- EPS (ttm)-0.38 Insider Own62.34% Shs Outstand56.98M Perf Week-26.70%
Market Cap4.18M Forward P/E- EPS next Y- Insider Trans0.00% Shs Float21.46M Perf Month-27.14%
Income-3.11M PEG- EPS next Q- Inst Own1.07% Short Float2.18% Perf Quarter-30.19%
Sales7.78M P/S0.54 EPS this Y- Inst Trans-20.18% Short Ratio0.13 Perf Half Y-64.42%
Book/sh0.21 P/B0.34 EPS next Y- ROA-19.72% Short Interest0.47M Perf Year-89.82%
Cash/sh0.02 P/C3.05 EPS next 5Y10.00% ROE-69.55% 52W Range0.07 - 0.80 Perf YTD-39.42%
Dividend Est.- P/FCF- EPS past 5Y29.70% ROI-41.13% 52W High-90.84% Beta0.92
Dividend TTM- Quick Ratio0.29 Sales past 5Y-9.79% Gross Margin-4.25% 52W Low1.81% ATR (14)0.01
Dividend Ex-Date- Current Ratio0.82 EPS Y/Y TTM50.85% Oper. Margin-35.16% RSI (14)33.80 Volatility10.26% 10.42%
Employees234 Debt/Eq0.88 Sales Y/Y TTM-3.59% Profit Margin-39.97% Recom- Target Price-
Option/ShortNo / Yes LT Debt/Eq0.24 EPS Q/Q62.81% Payout- Rel Volume0.94 Prev Close0.07
Sales Surprise- EPS Surprise- Sales Q/Q-8.26% Earnings- Avg Volume3.64M Price0.07
SMA20-20.86% SMA50-26.11% SMA200-61.72% Trades Volume3,436,160 Change1.81%
Date Action Analyst Rating Change Price Target Change
Jan-08-10Initiated Rodman & Renshaw Mkt Outperform $6
Feb-23-24 04:05PM
Nov-29-23 08:00AM
Aug-23-23 07:34PM
Aug-09-23 08:30AM
Feb-24-23 04:05PM
08:00AM Loading…
Dec-28-22 08:00AM
Dec-15-22 08:00AM
Dec-05-22 08:00AM
Dec-02-22 04:10PM
Oct-01-22 10:05PM
Jul-18-22 08:00AM
Jun-22-22 05:00PM
Mar-31-22 08:00AM
Nov-12-21 04:30PM
Aug-13-21 04:30PM
09:00AM Loading…
Aug-05-21 09:00AM
Jun-09-21 08:00AM
May-14-21 04:30PM
Apr-19-21 08:30AM
Mar-26-21 05:00PM
Nov-13-20 04:10PM
Oct-11-20 09:23AM
Sep-21-20 08:30AM
Aug-14-20 06:30AM
Aug-11-20 10:10AM
Jun-04-20 07:59PM
May-15-20 06:30AM
Apr-15-20 08:00AM
Apr-14-20 04:30PM
01:17AM Loading…
Apr-05-20 01:17AM
Mar-31-20 06:30AM
Mar-13-20 08:30AM
Mar-02-20 07:00AM
Dec-31-19 08:01AM
Nov-15-19 08:00AM
Oct-28-19 07:39AM
Sep-13-19 07:17AM
Sep-11-19 08:00AM
Sep-06-19 08:31AM
Aug-15-19 06:30AM
May-21-19 07:56PM
May-15-19 06:00AM
May-07-19 08:00AM
Mar-29-19 06:00AM
Jan-08-19 12:58PM
Nov-23-18 08:55AM
Nov-15-18 06:00AM
Nov-13-18 08:00AM
Nov-12-18 08:00AM
Oct-10-18 06:44PM
Aug-15-18 06:00AM
Aug-06-18 08:45AM
May-15-18 08:00AM
May-08-18 08:00AM
Apr-06-18 07:40AM
Apr-05-18 07:10AM
Apr-03-18 06:00AM
Mar-22-18 08:00AM
Dec-01-17 07:58AM
Nov-15-17 06:00AM
Nov-08-17 12:20PM
Nov-07-17 08:00AM
Oct-24-17 03:48PM
Sep-26-17 12:03PM
Sep-14-17 07:40AM
Sep-12-17 04:05PM
Aug-16-17 10:08AM
Aug-15-17 06:00AM
Aug-08-17 06:00AM
May-24-17 09:18AM
May-17-17 08:30AM
May-12-17 06:00AM
May-08-17 06:00AM
Apr-04-17 08:41AM
Mar-31-17 06:11AM
Mar-27-17 06:00AM
Dec-28-16 04:06PM
Dec-13-16 04:08PM
Dec-02-16 04:11PM
Nov-22-16 01:04PM
Nov-18-16 11:50AM
Nov-15-16 06:00AM
Nov-14-16 04:12PM
Nov-07-16 08:00AM
Aug-12-16 06:00AM
Aug-11-16 04:27PM
Aug-01-16 06:00AM
Jun-06-16 12:12PM
May-17-16 06:00AM
May-16-16 05:17PM
May-05-16 06:00AM
Apr-05-16 11:33AM
Mar-31-16 06:00AM
Mar-30-16 04:21PM
Mar-18-16 06:00AM
Dec-28-15 07:50AM
China Pharma Holdings, Inc. engages in the development, manufacture, and marketing of pharmaceutical products. The firm's product portfolio includes Central Nervous System (CNS) and Cerebral-Cardiovascular Diseases, Anti-infection and Respiratory Diseases, Digestive Diseases, Comprehensive Healthcare, and Protective Products. The company was founded by Zhi Lin Li on January 28, 1999 and is headquartered in Haikou, China.